Latest Breaking News On - Study topline data planned - Page 1 : comparemela.com

/PRNewswire/ Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies.

Sylvia wheelerLisa kelly croswellProgeroid laminopathiesDavid corySarah mathiesonCompany annualNational institutes of healthEuropean commissionDrug administrationPrnewswire eiger biopharmaceuticals incEiger biopharmaceuticals incAnges incCorporate affairsActive dialoguePotential peginterferon lambdaStudy topline data planned